Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.

Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations. Br J Cancer. 2019 01; 120(2):247-255.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antigens, CD
Aromatase Inhibitors
Breast
Breast Neoplasms
Cadherins
Class I Phosphatidylinositol 3-Kinases
Drug Resistance, Neoplasm
Estrogen Receptor alpha
Estrogens
Female
Gene Expression Regulation, Neoplastic
Humans
MAP Kinase Kinase 4
Middle Aged
Mutation
Neoplasm Staging
Receptor, ErbB-2

authors with profiles

Alexander Pearson